We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Nearly Transparent Mice Offers Potential of Whole-Organism Imaging

By LabMedica International staff writers
Posted on 23 Nov 2014
Japanese researchers have developed a method that combines tissue decolorization and light-sheet fluorescent microscopy to take extremely detailed images of the interior of individual organs and even entire organisms. More...
The research creates new possibilities for understanding the way organisms work—the “holy grail” of systems biology—by allowing scientists to create tissues and whole organisms transparent and then image them at extremely precise, single-cell resolution.

To achieve this feat, the researchers, from the RIKEN Quantitative Biology Center (Saitama, Japan), together with collaborators from the University of Tokyo (Japan), led by Dr. Hiroki Ueda, began with a technology called CUBIC (clear, unobstructed brain imaging cocktails and computational analysis), which they had previously used to image whole brains. Though brain tissue is lipid-rich, and thus susceptible to many clearance methods, other parts of the body contain many molecular subunits known as chromophores, which absorb light. One chromophore, heme, which forms part of hemoglobin, is present in most tissues of the body and blocks light. The group decided to focus on this issue and discovered, in a surprise finding, that the aminoalcohols included in the CUBIC reagent could elute the heme from the hemoglobin, and by doing so, make other organs dramatically more transparent.

Using the technology, the scientists captured images of mouse brains, hearts, lungs, kidneys, and livers, and then went on to attempt the technology on infant and adult mice, and discovered that in all instances they could get clear tissues. They used the technique of light-sheet fluorescent microscopy, which involves taking slices of tissues without having to actually cut into it, to gain three-dimensional (3-D) images of the organs. To assess the feasibility of the method, they examined the pancreases of diabetic and non-diabetic mice, and found distinct discrepancies in the isles of Langerhans, the structures in the pancreas that produce insulin.

Although these methods could not be used in living organisms, since they require the tissues to be fixed using reagents, they could, according to Kazuki Tainaka, the first author of the paper, be very useful for gaining new understanding of the 3D structure of organs and how certain genes are expressed in various tissues. He said, “We were very surprised that the entire body of infant and adult mice could be made nearly transparent by a direct transcardial CUBIC perfusion coupled with a two-week clearing protocol. It allowed us to see cellular networks inside tissues, which is one of the fundamental challenges in biology and medicine.”

According to Dr. Ueda, who led the research team, “This new method could be used for 3D pathology, anatomic studies, and immunohistochemistry of entire organisms. For example, it could be used to study how embryos develop or how cancer and autoimmune diseases develop at the cellular level, leading to a deeper understanding of such diseases and perhaps to new therapeutic strategies. It could lead to the achievement of one of our great dreams, organism-level systems biology based on whole-body imaging at single-cell resolution.”

Although this is a significant finding, more research is needed, according to the investigators. In the future, the group plans to make improvements to the microscopy method to allow for the rapid imaging of whole bodies of adult mice or larger samples such as human brains, and to apply this technology to better understand autoimmune and psychiatric diseases.

The research was published November 6, 2014, in the journal Cell.

Related Links:

RIKEN Quantitative Biology Center
University of Tokyo



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated PCR System
OnePCR
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.